Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • XLP vs MRNA✓SelectedUSD · MRNAXLP vs MRNA performance historyLatest closeAs of-1.23%11/17
Stock and ETF performance explorer

XLP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+42.8%
MRNA return
+168.0%
Excess return
-125.3%
Maximum drawdown
-9.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.2%-3.9%+2.7%-1.2%
7D+0.5%-17.6%+18.0%+0.6%
30D+4.4%-5.1%+9.5%+4.4%
3M+8.7%+220.8%-212.1%+6.9%
6M+9.5%+321.7%-312.2%+7.0%
YTD+20.0%+601.3%-581.2%+15.4%
1Y+22.4%+735.2%-712.8%+17.0%
3Y+42.8%+170.5%-127.8%+40.2%
All+42.8%+168.0%-125.3%+40.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling